Sarah McGuire
Gerontology · Blackwell, OKNPI 1770706244
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 131 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $669 and has fallen 54.5% since, to $304 in 2025.
Across 131 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$473
- GSK$401
- AstraZeneca$165
- Otsuka America Pharmaceutical, Inc.$158
- Astellas Pharma US Inc$155
- Novo Nordisk$151
- plus $694 from 16 others
What the payments were for
- Food & beverage$2,09595%
- Education$1035%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $473 |
| GSK | 22 | $401 |
| AstraZeneca | 8 | $165 |
| Otsuka America Pharmaceutical, Inc. | 14 | $158 |
| Astellas Pharma US Inc | 3 | $155 |
| Novo Nordisk | 11 | $151 |
| Exact Sciences | 8 | $134 |
| Lilly USA, LLC | 8 | $125 |
| Dexcom, Inc. | 4 | $70 |
| Boehringer Ingelheim | 3 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $49 |
| Lundbeck LLC | 2 | $46 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Mylan Specialty L.p. | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Abbott | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Viatris Specialty LLC | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Merck | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$2,198 in reported general payments places this provider in the 70th percentile of 73 gerontology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 160 | $236,916 |
| JardianceEmpagliflozin | 68 | $59,025 |
| TrulicityDulaglutide | 43 | $57,216 |
| EliquisApixaban | 49 | $47,781 |
| MounjaroTirzepatide | 29 | $31,917 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $19,739 |
| RexultiBrexpiprazole | 12 | $16,603 |
| Nurtec OdtRimegepant Sulfate | 17 | $15,772 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $15,689 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $15,228 |
| JanuviaSitagliptin Phosphate | 16 | $12,477 |
| LinzessLinaclotide | 13 | $11,008 |
| XareltoRivaroxaban | 11 | $9,267 |
| MovantikNaloxegol Oxalate | 22 | $8,639 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $7,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $151 | $236,916160 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $125 | $89,13372 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $50 | $74,71382 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $401 | $22,27835 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $158 | $16,60312 claims |
| MerckJanuvia | $15 | $12,47716 claims |
| AbbVieLinzess | $473 | $11,00813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 73 gerontology providers in Oklahoma.
Other gerontology in Blackwell
- Whitney SimmonsOklahoma City$40K
- Christy CovingtonOklahoma City$12K
- Amanda SpencerNorman$8K
- Shelley TriplettTulsa$7K
- Stacie HanesOklahoma City$6K
- Justin RobertsMuskogee$6K
- Kelly SpychalskiAda$6K
- Samantha TuckerNorman$6K
- Kjerista TiptonTulsa$6K
- Bailey StremmeTulsa$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.